✦ LIBER ✦

In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype

✍ Scribed by Donal J. O’Gorman; Obada Yousif; Gordon Dixon; Siobhan McQuaid; Elaine Murphy; Yousif Rahman; Declan Gasparro; Giovanni Pacini; Philip Newsholme; John J. Nolan

Book ID: 116406121
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 275 KB
Volume: 80
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2007.12.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression to insulin deficiency in Kor

Progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibody

✍ S. A. Lee; W. J. Lee; E. H. Kim; J. H. Yu; C. H. Jung; E. H. Koh; M.-S. Kim; J.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

IA-2 antibody prevalence and risk assess

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)

✍ G. F. Bottazzo; E. Bosi; C. A. Cull; E. Bonifacio; M. Locatelli; P. Zimmet; I. R 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 99 KB

IA-2 antibody prevalence and risk assess

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)

✍ G. F. Bottazzo; E. Bosi; C. A. Cull; E. Bonifacio; M. Locatelli; P. Zimmet; I. R 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 37 KB

Autoantibodies to GAD, IA-2 and insulin

Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings

✍ Sari Korhonen; Maria M. Knip; Petri Kulmala; Kaisa Savola; Hans K. Åkerblom; Mik 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Background Islet cell antibodies (ICA) represent a heterogenous group of autoantibodies to diabetes‐associated antigens, including glutamic acid decarboxylase (GAD) and the IA‐2 protein. The objectives of the present study were to compare the prevalence of autoantibodies to known bi

A 26-week, placebo- and pioglitazone-con

A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus

✍ H. S. Chou; K. E. Truitt; J. B. Moberly; D. Merante; Y. Choi; Y. Mun; A. Pfützne 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

Effects of JNJ-38431055, a novel GPR119

Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes

✍ L. B. Katz; J. J. Gambale; P. L. Rothenberg; S. R. Vanapalli; N. Vaccaro; L. Xi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB